European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live08-15

European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 1.22% to 1,444.66 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and internet browser company Opera (OPRA), which rose 2.7% and 2.6% respectively. They were followed by ING (ING), which was up 2%.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and semiconductor company Sequans Communications (SQNS), which fell 3.5% and 1.8% respectively. They were followed by accommodations booking company trivago (TRVG), which was down 1.7%.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and NuCana (NCNA), which advanced 5.2% and 5% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which increased 4.5% and 3.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which lost 3.3% and 3.1% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and National Grid (NGG), which were down 1.5% and 0.8% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment